Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Academy of Translational Medicine Professionals Launched Certification Program in Translational Medicine (PCTM)

Published: Wednesday, January 22, 2014
Last Updated: Wednesday, January 22, 2014
Bookmark and Share
Program is designed to set the standards for excellence in field of translational medicine.

Professional Certification in Translational Medicine (PCTM) program is designed by the Academy of Translational Medicine Professionals (ATMP) to set the standards for excellence in field of translational medicine and to promote and maintain high quality in clinical research through the evaluation of the applicant’s translational medicine knowledge and track record.

Clinicians and graduates holding degrees or having experience in relevant disciplines can apply for the certification program. Based on applicants documented training and experience evaluation, applicants are assigned category one or category two. Parameters of evaluation include: number and quality (impact factor) of publications, duration and type of international experience, biomedical grants personally supervised, presentations and participation in international biomedical conferences.

Category one is for junior clinicians, investigators and graduates holding degrees with less than three years experience who must successfully complete the online qualifying examination in order to receive the certification. Qualifying examination for category one applicant will evaluate the applicant’s knowledge in themes and topics relevant to translational medicine such as Biomarkers, Omics Sciences, Data Management, Clinical Trials Knowledge, Disease modelling concepts and approaches in Community & Preventive Medicine.

Category two is for Professionals with 3 more years of relevant extensive experience. Applicants within this category will receive certification based on evaluation of their track records and experience without qualifying examination.

Professional Certification in Translational Medicine (PCTM) program is accredited by the European Society for Translational Medicine (EUSTM) and the Global Translational Medicine Consortium (GTMC).

 



Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!